Jiangxi Long Life Bio-Pharmaceutical Co., Ltd

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Jiangxi Long Life Bio-pharmaceutical Co., Ltd

15 YRS

Jiangxi, China

CNY 188.9 Million

33300 m²

100-500 people

Main Products: (2R,3S)-2-((R)-1-(3,5-Bis(Trifluoromethyl)Phenyl)Ethoxy)-3-(4-Fluorophenyl)Morpholine Hydrochloride / 3-(4-Phenoxyphenyl)-1H-Pyrazolo[3,4-d]Pyrimidin-4-Amine / Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid / (S)-(-)-3-(N-Methylamino)-1-(2-Thienyl)-1-Propanol / (2R,4S)-5-([1,1'-Biphenyl]-4-Yl)-4-((Tert-Butoxycarbonyl)Amino)-2-Methylpentanoic Acid / Lcz696 Intemediate

Jiangxi, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturing

Total Employees

100-500 People

Plant Size

50 Acres

Production Experience

15+ Years

Registered Capital

CNY 188.9 Million

MAIN
PRODUCTS

1/1

(2R,3S)-2-((R)-1-(3,5-Bis(Trifluoromethyl)Phenyl)Ethoxy)-3-(4-Fluorophenyl)Morpholine Hydrochloride

CAS: 171482-05-6

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

3-(4-Phenoxyphenyl)-1H-Pyrazolo[3,4-d]Pyrimidin-4-Amine

1/3

3-(4-Phenoxyphenyl)-1H-Pyrazolo[3,4-d]Pyrimidin-4-Amine

CAS: 330786-24-8

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid

1/3

(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid

CAS: 486460-00-8

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

ABOUT US

Jiangxi Long Life Bio-pharmaceutical Co., Ltd

Jiangxi LongLife Bio-pharmaceuticalCo., Ltd. was founded by Dr. James Wu in 2009. As a subsidiary of Chiral Quest(Suzhou) Co., Ltd., Longlife is dedicated to the development and industrialization of innovative drugs and high-end generic drugs. Located in Jinxian Industrial Park, Jiangxi province, LongLife covers an area of 108,000 square meters in total with the plant construction area, more than13,000 square meters. The company has invested more than 23 million dollars toestablish a new plant which accords with the standard of cGMP. In year 2018, LongLife passed US FDA audit. LongLife has serials of products involve in anti-cancer, anti-diabetic,anti-HIV and anti-depressant. Our main products including the intermediates of Duloxetine,Sitagliptin, Sacubitril, Dolutegravir, Ibrutinib, Upadacitinib Aprepitant, etc.We innovate the manufacturing route of Duloxetine, cut down the cost of raw material and manufacturing, meanwhile keep the high level of quality. In year 2020, with the merge with Suzhou Pengxu Pharmatech Co., Ltd., both Longlife (manufacturing site) and Pengxu (R&Dsite) become the wholly owned subsidiary of Chiral Quest (Suzhou) Co., Ltd. With the advantage of advanced technology, experienced management team and high-quality talents, Jiangxi Longlife will develop into a first-class and highly competitive international pharmaceutical enterprise.